The UK’s move to leave the European Medicine Agency (EMA) has left doctors on edge.
Dr Mark Taylor, who runs the National Health Service (NHS) London practice, said he was “pretty worried” the decision would lead to a “complete shift in the way we treat people”.
Dr Taylor, an orthopaedic surgeon, said the decision was made after “a consultation with colleagues from the NHS and doctors from other specialist groups in the NHS” to consider how the health service could adapt to the new EU regulations.
He said it was “clear that the decision has led to a complete shift in our approach to treating people and it is very concerning”.
The change has come as a blow to the NHS’s reputation in Europe, and there has been widespread concern about how the move could affect patient care.
The European Commission said the change was aimed at protecting patients from unnecessary tests, as well as preventing the misuse of expensive and potentially harmful drugs.
But Dr Taylor said: “We’ve had to adapt, and we’re trying to do that as quickly as possible, because we know it could mean we lose patients.”
We’ve got a big, complex medical problem in our country, and the best thing we can do is to try and minimise harm to the patients.
“We know that the risks are so great.
I don’t think that’s a good look.”UK patients can only get specialist treatment from the EMA if they are treated in a private clinic in the UK.
The EMA regulates the supply of drugs and medical devices across Europe, with many countries deciding to have their own market.
The EU’s move towards a single market has already seen the UK become the second biggest market for generic drugs.
However, in June, it was revealed that UK patients could be able to buy a cheaper version of a generic drug from the European Patent Office, but could only get it if they paid for the full version from their NHS.
The change in how medicines are sold has already resulted in the closure of several hospitals in London.
Dr Taylor said the hospital closure was due to “serious concerns” about the quality of care in hospitals across the country.
“Our biggest concern was the level of hospitalisation that we’re seeing.
We’ve got one of the highest hospitalisation rates in Europe,” he said.”
The NHS is facing a huge challenge because of the changes we’re going through.”UK doctors have welcomed the news that they could no longer receive referrals for specialist tests, including a drug called nalidixic acid.”
I know a lot of people are concerned about the cost of their care and the lack of support that they are getting.”
The NHS is facing a huge challenge because of the changes we’re going through.”UK doctors have welcomed the news that they could no longer receive referrals for specialist tests, including a drug called nalidixic acid.
But it is thought some specialists are likely to still receive tests from the EU as long as the EEA rules are not changed.
The move is being criticised by some in the health industry, which argues the change could have devastating consequences for patients.
But the Health Secretary, Jeremy Hunt, said it could also help doctors.”
If the European Commission had their way, this would mean that people could now only get a single treatment from an NHS specialist in the country,” he told BBC Radio 4’s Today programme.”
That’s a problem for our NHS and it’s a big problem for the country.